囊性甲状腺结节经皮乙醇注射并发症的患病率与管理:文献系统综述与Meta分析
该研究通过系统综述与Meta分析评估囊性甲状腺结节经皮乙醇注射(PEI)并发症的患病率及管理,纳入48项观察性研究及本机构经验共3670个囊性甲状腺结节。总体并发症患病率32%(CI 25-40%,I2 92.7%),轻微并发症32%(CI 25-40%,I2 92.7%),严重并发症2%(CI 1-2%,I2 0%)。局部疼痛21%(CI 16-27%,I2 90.3%),发声困难1%(CI 1-2%,I2 0)。作者认为PEI总体安全,并发症多轻微且短暂。
要点
- PEI治疗囊性甲状腺结节总体并发症患病率32%,严重并发症仅2%。
- 局部疼痛最常见(21%),通常短暂轻微,有时需镇痛药数日。
- 发声困难患病率1%,为严重并发症但少见且短暂,可持续数小时至12个月。
核心结论
- PEI治疗良性囊性甲状腺结节的并发症相对常见,但大多数为轻微且通常短暂,无需治疗。
- 发声困难是严重并发症,但少见且短暂。
- 作者认为PEI治疗囊性甲状腺结节可被视为总体安全的技术。
研究设计与样本
- 系统综述与Meta分析,纳入已发表的PEI治疗囊性甲状腺结节的观察性研究。
- 另纳入意大利坎帕尼亚路易吉·万维泰利大学医院内分泌与代谢病科2021年6月1日至2024年3月31日连续接受PEI的细胞学良性囊性甲状腺结节患者的回顾性收集的并发症数据。
- 文献检索获得1189项研究,最终纳入48项研究加本机构经验,共3670个囊性甲状腺结节。
- 纳入研究总体质量判定为一般。
- 采用随机效应Meta分析患病率数据,用I2统计量量化异质性。
主要发现
- PEI总体并发症患病率为32%(CI 25-40%,I2 92.7%,3195个甲状腺结节中967个)。
- PEI轻微并发症患病率为32%(CI 25-40%,I2 92.7%,3195个甲状腺结节中952个)。
- PEI严重并发症患病率为2%(CI 1-2%,I2 0%,3670个甲状腺结节中22个)。
- 局部疼痛合并患病率为21%(CI 16-27%,I2 90.3),通常短暂轻微,有时中度,需镇痛药数日。
- 发声困难合并患病率为1%(CI 1-2%,I2 0),为暂时性,可持续数小时至PEI后12个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 纳入研究的总体质量判定为一般。
- 总体并发症和轻微并发症的异质性I2均为92.7%,局部疼痛的异质性I2为90.3%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: We assessed the prevalence of complications from percutaneous ethanol injection (PEI) for benign and cystic thyroid nodules (CTNs) and their management. Methods: We conducted a systematic review with meta-analysis of data from published observational studies on PEI of CTNs. We also included unpublished retrospectively collected data on complications after PEI from all consecutive patients with cytologically benign CTNs who underwent PEI at the Unit of Endocrinology and Metabolic Diseases, AOU University of Campania Luigi Vanvitelli (Naples, Italy) between June 1, 2021, and March 31, 2024. A random effects meta-analysis was performed on the prevalence rate data. Pooled prevalence data were presented with confidence intervals (CIs). The I2 statistic index was used to quantify the heterogeneity. The details of the complications and the management were qualitatively described. Results: The literature search yielded 1189 studies, of which 48 studies were included in the systematic review and meta-analysis, in addition to our institutional experience (3670 CTNs in total). The overall quality of each included study was judged as fair. The prevalence of "Overall" complications of PEI was 32% ([CI 25-40%], I2 92.7%, 967 of 3195 thyroid nodules [TNs]). The prevalence of "Minor" complications of PEI was 32% ([CI 25-40%], I2 92.7%, 952 of 3195 TNs). The prevalence of "Major" complications of PEI was 2% ([CI 1-2%], I2 0%, 22 of 3670 TNs). Sensitivity analyses did not modify the results. The pooled prevalence rate of local pain was 21% (CI [16-27] I2 90.3). Local pain was typically transient and mild, sometimes moderate, and requiring analgesics for few days. The pooled prevalence rate of dysphonia was 1% (CI [1-2], I2 0). Dysphonia was transient and could last from several hours to 12 months after PEI. Conclusions: Complications of PEI for benign and CTNs are relatively common, but most are minor and usually transient, not requiring treatment. Dysphonia was a major complication, but it was uncommon and transient. PEI for CTNs could be considered a generally safe technique.
引用
- Scappaticcio L, Ferrazzano P, Di Martino N, et al. Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis. Thyroid. 2024. PMID: 39030844. doi:10.1089/thy.2024.0241
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。